The state of New Jersey currently has 21 active clinical trials seeking participants for Multiple Sclerosis research studies. These trials are conducted in various cities, including New Brunswick, Hackensack, Newark and Morristown.
Effects of Cycling and Virtual Reality on Thinking Speed in Persons With MS (PACE-MS)
Recruiting
To compare the effects of cycling exercise with different types of virtual reality on processing/thinking speed in persons with multiple sclerosis (MS).
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
02/13/2024
Locations: Kessler Foundation, East Hanover, New Jersey
Conditions: Multiple Sclerosis
Examining Effects of Ocrevus on Cognitive Fatigue Using fMRI
Recruiting
The purpose of this research study is to investigate the effectiveness of MS Disease modifying medications on cognitive fatigue in persons with relapsing remitting multiple sclerosis (RRMS). Cognitive fatigue is the kind of fatigue that occurs after intense mental concentration as after a session of problem solving.
Gender:
All
Ages:
Between 18 years and 64 years
Trial Updated:
02/13/2024
Locations: Kessler Foundation, West Orange, New Jersey
Conditions: Multiple Sclerosis, Relapsing-Remitting
Examining Effects of Tysabri on Cognitive Fatigue Using fMRI
Recruiting
The purpose of this research study is to investigate the effectiveness of Tysabri on cognitive fatigue in persons with Relapsing-Remitting Multiple Sclerosis (RRMS). Cognitive fatigue is the kind of fatigue that occurs after intense mental concentration as after a session of problem solving.
Gender:
All
Ages:
Between 18 years and 64 years
Trial Updated:
02/13/2024
Locations: Kessler Foundation, West Orange, New Jersey
Conditions: Multiple Sclerosis, Relapsing-Remitting
A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation
Recruiting
This study will evaluate if relapsing-remitting MS patients that have not had a relapse in the past year would benefit from a switch to ofatumumab versus staying on their continued current therapy. This study will also look at whether an elevated serum neurofilament light (NfL) level predicts enhanced benefit from a switch to ofatumumab.
Gender:
All
Ages:
Between 18 years and 50 years
Trial Updated:
02/01/2024
Locations: Novartis Investigative Site, Neptune, New Jersey
Conditions: Relapsing-Remitting Multiple Sclerosis
WOE of Anti-CD20 Therapies
Recruiting
The nature, intensity, and prevalence of this wearing-off effect remain poorly understood. To our knowledge, there is no consensus in the literature on what symptoms constitute a wearing-off effect, nor is there a single validated scale that measures wearing-off effect. The current study will explore the wearing-off effect associated with OCR and OMB, using a variety of validated scales assessing MS symptoms (i.e., fatigue, mobility, pain, depression, cognition), as well as some global questions... Read More
Gender:
All
Ages:
Between 21 years and 85 years
Trial Updated:
01/26/2024
Locations: Novartis Investigational site, East Hanover, New Jersey
Conditions: Multiple Sclerosis
Meeting an Unmet Need in Multiple Sclerosis
Recruiting
The primary objectives of this study is to examine the efficacy of the Unified Protocol in decreasing depression and anxiety among individuals with MS and the secondary outcomes (e.g., improved well-being, QOL, coping, etc.) that may occur in tandem.
Gender:
All
Ages:
18 years and above
Trial Updated:
07/12/2023
Locations: Kessler Foundation, East Hanover, New Jersey
Conditions: Multiple Sclerosis
Comparison of Two Physical Activity Interventions in Individuals With Multiple Sclerosis
Recruiting
This study will examine the effectiveness of aquatic therapy on a range of MS-related symptoms such as cognition, mood, fatigue and quality of life (QOL).
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
12/01/2022
Locations: Kessler Foundation, East Hanover, New Jersey
Conditions: Multiple Sclerosis
Computerized Cognitive Rehabilitation in MS Patients
Recruiting
This study examines a home-based computerized cognitive rehabilitation intervention in adults with multiple sclerosis compared to placebo (videogame). Patients are assessed through pre-and post neuropsychological testing.
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
11/16/2022
Locations: Robert Wood Johnson Medical School, New Brunswick, New Jersey
Conditions: Multiple Sclerosis, Cognitive Impairment
Reinventing Yourself With Multiple Sclerosis (MS)
Recruiting
Given the knowledge that detriments in QOL, well-being, and participation are common in MS and attributable in a large part to individual, person-specific factors (e.g., self-efficacy), efforts to develop interventions aimed at addressing these factors is well needed and likely to have a significant impact. The proposed investigation will consist of two phases involving participant recruitment and data collection. Phase 1 will consist of a focus group aimed at identifying the unique needs of ind... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
10/12/2022
Locations: Kessler Foundation, East Hanover, New Jersey
Conditions: Multiple Sclerosis